Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathy Miller

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Plos One|June 9, 2016
SQSTM1 Mutations and GlaucomaTodd E Scheetz, Ben R Roos, Frances Solivan-Timpe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2003
Design, construction, and in vitro analyses of multivalent antibodiesKathy Miller, Gloria Meng, Jun Liu, et al.
Psycho-Oncology|September 21, 2016
Symptom experiences in metastatic breast cancer patients: relationships to activity engagement, value-based living, and psychological inflexibilityCatherine E Mosher, Danielle B Tometich, Adam Hirsh, et al.
The Oncologist|February 22, 2017
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast CancerLinda T Vahdat, Rachel Layman, Denise A Yardley, et al.
European Journal of Medical Genetics|April 27, 2019
Validation of concurrent preimplantation genetic testing for polygenic and monogenic disorders, structural rearrangements, and whole and segmental chromosome aneuploidy with a single universal platformNathan R Treff, Raymond Zimmerman, Elan Bechor, et al.
Oncogene|April 5, 2005
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cellsBrent W Sutherland, Jill Kucab, Joyce Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapyGail D Lewis Phillips, Carter T Fields, Guangmin Li, et al.
JAMA Oncology|November 6, 2015
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast CancerChau Dang, Hao Guo, Julie Najita, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2018
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast CancerTiffany A Traina, Kathy Miller, Denise A Yardley, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Plos One|June 9, 2016
SQSTM1 Mutations and GlaucomaTodd E Scheetz, Ben R Roos, Frances Solivan-Timpe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2003
Design, construction, and in vitro analyses of multivalent antibodiesKathy Miller, Gloria Meng, Jun Liu, et al.
Psycho-Oncology|September 21, 2016
Symptom experiences in metastatic breast cancer patients: relationships to activity engagement, value-based living, and psychological inflexibilityCatherine E Mosher, Danielle B Tometich, Adam Hirsh, et al.
The Oncologist|February 22, 2017
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast CancerLinda T Vahdat, Rachel Layman, Denise A Yardley, et al.
European Journal of Medical Genetics|April 27, 2019
Validation of concurrent preimplantation genetic testing for polygenic and monogenic disorders, structural rearrangements, and whole and segmental chromosome aneuploidy with a single universal platformNathan R Treff, Raymond Zimmerman, Elan Bechor, et al.
Oncogene|April 5, 2005
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cellsBrent W Sutherland, Jill Kucab, Joyce Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Dual targeting of HER2-positive cancer with trastuzumab emtansine and pertuzumab: critical role for neuregulin blockade in antitumor response to combination therapyGail D Lewis Phillips, Carter T Fields, Guangmin Li, et al.
JAMA Oncology|November 6, 2015
Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast CancerChau Dang, Hao Guo, Julie Najita, et al.
Molecular Cancer Research : MCR|May 23, 2013
Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survivalRichard A Burkhart, Yu Peng, Zoë A Norris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2018
Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast CancerTiffany A Traina, Kathy Miller, Denise A Yardley, et al.
Pageof 5